Sleeping Beauty transposon system harboring HRAS, c-Myc and shp53 induces sarcomatoid carcinomas in mouse skin
Author(s) -
Sun-Young Jung,
Simon Weonsang Ro,
Geunyoung Jung,
HyeLim Ju,
Eunsil Yu,
WooChan Son
Publication year - 2013
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2013.2264
Subject(s) - hras , sleeping beauty transposon system , biology , carcinogenesis , oncogene , immunohistochemistry , insertional mutagenesis , sarcomatoid carcinoma , pathology , phenotype , molecular medicine , cancer research , transposable element , cancer , cell cycle , medicine , gene , immunology , genetics , colorectal cancer , genome , kras
The Sleeping Beauty transposon system is used as a tool for insertionalmutagenesis and oncogenesis. However, little is known about the exact histologicalphenotype of the tumors induced. Thus, we used immunohistochemical markers toenable histological identification of the type of tumor induced by subcutaneousinjection of the HRAS, c-Myc and shp53 oncogenes in female C57BL/6 mice. The tumorwas removed when it reached 100 mm3 in volume. Subsequently, we used 13 immunohistochemicalmarkers to histologically identify the tumor type. The results suggested thatthe morphology of the tumor was similar to that of sarcomatoid carcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom